To understand whether combination antiretroviral therapy ( cART ) has been optimized , we asked whether 3-drug protease inhibitor ( PI ) - based cART intensified with raltegravir and maraviroc and initiated during early infection would improve outcomes when compared with similarly applied 3-drug PI-based cART .